Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LYEL · against 1,372 other Healthcare companies
Ranked #268 of 1,373 · scores higher than 81% of peers · safety percentile 81
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 80–89, including LYEL · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | LYEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.20× | 0.24× | 54% | 33% | |
| BetaLower is better · 1,320 reported | -0.03 | 0.53 | 94% | 33% | |
| Current ratioHigher is better · 1,338 reported | 5.36× | 2.62× | 75% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 264 | 10.1B USD | 81 | 61 | |
| 265 | 63.5B JPY (≈$432M) |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 81 |
| 57 |
| 266 | 143.3B JPY (≈$975M) | 81 | 61 |
| 267 | 109.3B JPY (≈$743M) | 81 | 76 |
| 268 | 264M USD | 81 | 24 |
| 269 | 3.9B CNY (≈$549M) | 80 | 61 |
| 270 | 142.5B INR (≈$1.7B) | 80 | 71 |
| 271 | 1.13T INR (≈$13.5B) | 80 | 61 |
| 272 | 20.5B INR (≈$246M) | 80 | 49 |